| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.99B | 2.37B | 2.69B | 2.91B | 2.65B | 2.26B |
| Gross Profit | 537.00M | 647.00M | 651.00M | 731.00M | 640.00M | 463.00M |
| EBITDA | 253.00M | 373.00M | 334.00M | 393.00M | 451.00M | 279.00M |
| Net Income | -1.00M | 66.00M | 33.00M | 89.00M | 164.00M | 35.00M |
Balance Sheet | ||||||
| Total Assets | 3.68B | 4.00B | 4.10B | 4.09B | 4.52B | 3.49B |
| Cash, Cash Equivalents and Short-Term Investments | 180.00M | 412.00M | 541.00M | 477.00M | 619.00M | 433.00M |
| Total Debt | 1.51B | 1.51B | 1.69B | 947.00M | 961.00M | 371.00M |
| Total Liabilities | 2.76B | 2.87B | 3.06B | 2.77B | 3.05B | 2.13B |
| Stockholders Equity | 907.00M | 1.12B | 1.01B | 1.27B | 1.42B | 1.32B |
Cash Flow | ||||||
| Free Cash Flow | 67.00M | 149.00M | 98.00M | 90.00M | 184.00M | 184.00M |
| Operating Cash Flow | 133.00M | 272.00M | 181.00M | 221.00M | 315.00M | 301.00M |
| Investing Cash Flow | -89.00M | -86.00M | -504.00M | -155.00M | -419.00M | -113.00M |
| Financing Cash Flow | -61.00M | -324.00M | 425.00M | -182.00M | 266.00M | -418.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | CHF4.91B | 17.98 | 23.37% | 2.93% | 5.79% | 13.20% | |
73 Outperform | CHF11.42B | 51.13 | 32.09% | 1.64% | 19.22% | 11.62% | |
70 Outperform | CHF2.12B | 28.56 | ― | 2.19% | 11.43% | 6.46% | |
65 Neutral | CHF3.73B | 16.54 | ― | 3.01% | -11.64% | -24.17% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | CHF1.04B | -1,036.13 | ― | 6.22% | -17.75% | 83.94% | |
54 Neutral | CHF4.35B | 15.71 | ― | 2.54% | -24.42% | 32.48% |
Oerlikon reported a strong performance in Q3 2025, with an 11% increase in order intake and a 2.9% rise in sales, despite challenges in end markets and geopolitical uncertainties. The company successfully placed CHF 350 million in senior bonds, reinforcing financial stability and confidence in its long-term strategy. The appointment of Marco Freidl and Dr. Andreas Weiss to the Executive Committee marks a strategic move towards Oerlikon’s pureplay future, with the divestment of Barmag expected to complete in Q4 2025.